We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Need to Rethink Business Model for Biogenerics
Generics Need to Rethink Business Model for Biogenerics
March 29, 2006
Generic biologics could debut in the U.S. market by 2009 and in the European Union (EU) by the end of 2006, according to a study by research group Datamonitor.